documents: FDA-2020-N-0026-0031

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2020-N-0026-0031 FDA FDA-2020-N-0026 Issuance of Priority Review Voucher; Rare Pediatric Disease Product; LIVMARLI (maralixibat) Notice Announcement 2024-08-28T04:00:00Z 2024 8 2024-08-28T04:00:00Z   2024-08-28T13:55:40Z 2024-19334 0 0 09000064866b0229

Links from other tables